🇺🇸 FDA

Company profile · Sponsor

Qilu

Qilu Pharmaceutical (Hainan) Co.,

EF7CBB3 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Qilu (EF7CBB3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EF7CBB3
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. QL2108 injection

    Qilu

    Atopic Dermatitis

    phase 1 small molecule completed

    1 trial

  2. QLS1128 A-Dose 1~5 and Ritonavir

    Qilu

    COVID-19

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Qilu?

Qilu (EF7CBB3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Qilu sponsor?

We track 2 ClinicalTrials.gov-linked programs for Qilu, including QL2108 injection and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Qilu company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.